ENTERO HEALTHCARE SOLUTIONS LTD Q1 RESULTS
Q-comm audits; modest Q1 for IT firms
Happy Wednesday! Due to recent hygiene lapses by quick commerce, the government has intensified surprise inspections of their warehouses. This and more in today’s ETtech Morning Dispatch.
Indian software sector earnings will remain modest in Q1: here’s why
Infosys and LTIMindtree are expected to lead a modest increase in average growth for Indian software service providers in the first quarter of FY25. However, previous top performers, Tata Consultancy Services (TCS) and HCLTech, may see pressure on profits and margins as they work to reignite growth.
Fresh capital raised via IPOs surges to a 9-year high, hints at private capex revival
Of the ₹33,610 crore raised by 37 companies so far in 2024, about 45%, or ₹15,190 crore, were through new shares, the highest proportion since 2015, when India Inc. raised nearly 48% fresh capital, according to data from primedatabase.com. The funds raised as fresh issues in 2024 were to either finance capital assets or retire existing debt obtained to build capacities, according to IPO documents.
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Cloudphysician raises $10.5 million in funding round led by Peak XV Partners
Online healthcare and technology solutions provider Cloudphysician has raised $10.5 million (about Rs 87.7 crore) in a funding round led by Peak XV Partners, along with Elevar Equity and venture debt firm Panthera Peak. The startup will use the capital to strengthen its presence in India, enter other countries and develop its AI platform.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
- Go To Page 1
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Cummins India Q4 Results: PAT grows to Rs 539 crore
Cummins India's profit after tax surged to Rs 538.86 crore in the March quarter, with expenses at Rs 1,829.19 crore compared to Rs 1,648.01 crore in the previous year.
TVS Supply Chain Solutions Q4 Results: Firm reports consolidated PAT of Rs 5.38 crore
TVS Supply Chain Solutions Ltd reported a profit after tax of Rs 5.38 crore for the quarter January-March 2024, with total income growing to Rs 2,433.06 crore from Rs 2,332.53 crore in the same quarter last year, but facing a consolidated net loss of Rs 90.49 crore for the year ending March 31, 2024.
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
Suzlon Energy Q4 Results: Net profit drops 21% YoY to Rs 254 crore
Renewable energy solutions provider Suzlon Energy on Friday reported nearly 21 per cent decline in consolidated net profit to Rs 254 crore in the March quarter mainly due to certain exceptional items.
Zaggle Q4 Results: Net profit jumps to Rs 19 crore
SaaS fintech platform Zaggle Prepaid Ocean Services on Thursday said its consolidated net profit more than doubled to Rs 19.15 crore in the March 2024 quarter. The company had reported a net profit of Rs 7.56 crore in the year-ago period, according to a regulatory filing.
Fortis Healthcare Q4 Results: Net profit jumps 47% YoY to Rs 203 crore
Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business.
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Metropolis Healthcare Q4 Results: Net profit rises 8% to Rs 36 crore
The diagnostic chain reported Rs 33.5 crore net profit in the corresponding quarter of the previous year. Revenue from operations grew by 11% YoY to Rs 313 crore.
Redington Q4 Results: Firm posts standalone profit of Rs 160.57 crore
Integrated technology solutions provider Redington Ltd has reported a standalone net profit for the January-March 2024 quarter at Rs 160.57 crore, the company said. The city-based company had registered a standalone net profits of Rs 124.91 crore during the corresponding quarter of previous year.
ABB India Q1 Results: Net profit jumps 87% to Rs 460 crore
During the quarter, consolidated revenues came in at Rs 3,080 crore, up 28% from Rs 2,411 crore in the year-ago period.
GE HealthCare Q1 Results: Co misses quarterly revenue estimates on weakness in China market
GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its shares tumbling as much as 12% before the bell.
CRISIL Q1 Results: Profit declines 5.5% YoY to Rs 138 crore; Rs 7 dividend declared
CRISIL Ltd reported a 5.5% YoY decline in consolidated net profit to Rs 138 crore for the March quarter, with revenue rising 3% YoY to Rs 738 crore. The Board approved an interim dividend of Rs 7 per share. Margins dropped to 26%, and EPS fell by 5% to Rs 18.84.
Goldman Sachs Q1 Results: Profit jumps 28% on investment banking strength
Goldman Sachs profit rose 28% in the first quarter, buoyed by a recovery in debt underwriting and dealmaking that boosted its investment banking unit, it reported on Monday.
Shares worth $21 billion to enter market in 4 months as IPO lock-in period expires for 66 companies
66 companies are set to see the lock-in period for pre-listing shareholders lifted between March 4 and June 29. This amounts to $21.1 billion in value terms. The value pertains to the total lock-up opening shares, but not all the shares may be sold, as a sizable portion is also held by promoters and group entities
IPO calendar: 4 new issues, 7 listings to drive primary market activity next week
In the upcoming week, mainboard IPOs of Juniper Hotels and GPT Healthcare will hit the street to raise over Rs 2,000 crore. Meanwhile, SME companies Zenith Drugs and Dream Roll Tech are also scheduled to launch their issues.
Entero Healthcare sees negative listing. Should investors exit?
Entero has incurred losses in the past three fiscal years, raising concerns about its financial sustainability and profitability. It also faces challenges with negative cash flows from all three major activities, impacting working capital requirements.
Entero Healthcare Solutions shares list at 2% discount to IPO price
Entero Healthcare's IPO debuted with a discount on BSE and NSE. Proceeds will be used for debt repayment, working capital, funding subsidiaries, and inorganic growth. The company has 73 warehouses and supply relationships with over 1,900 healthcare product manufacturers. The target addressable market is valued at Rs 2.7 lakh crore.
Entero Healthcare Solutions IPO allotment: Check status, GMP, listing date and other details
To check the status of Entero Healthcare Solutions allotment through the registrar, which is Bigshare Services in this case, kindly follow the below steps.
Entero Healthcare is going to expand more into tier II, tier III cities now
"In the last three years, our average annual growth rate has been 36% and once the IPO proceeds and we receive that money, we will be even more aggressive in terms of pursuing growth opportunities. In terms of business mix, 95% is coming from distribution services, but we also provide a lot of value-added services to these companies in terms of providing marketing and promotion services as well but that contributes less than 5% of our business as of now."
Massive growth opportunities for healthcare industry in India: Entero Healthcare MD
“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-and-a-half thousand hospitals.”
Entero Healthcare's Rs 1,600-cr IPO biggest so far in 2024: 10 things to know before subscribing to the issue
The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.
Load More
